• April 8 (MON)
  • April 9 (TUE)
  • April 10 (WED)
April 8 (Mon)
09:00 - 10:20 KSAT Workshop 1
Chair: Yoon Soo Park (Yonsei University College of Medicine, Korea)
10:20 - 11:40 KSAT Workshop 2
Chair: Shin-Woo Kim (Kyungpook National University School of Medicine, Korea)

Symposium 1

Difficult-to-treat Pseudomonas aeruginsa & Carbapenem-resistant Acinetobacter

13:00 - 14:30

S1-1. Mechanisms and epidemiology of multiresistant non-fermenters

- David M. Livermore (University of East Anglia, UK)

S1-2. Clinical implications and treatment of serious infections due to carbapenem resistant Pseudomonas aeruginosa

- David Paterson (National University of Singapore, Singapore)

S1-3. Epidemiology and Treatment of Serious Infections Due to Carbapenem Resistant Acinetobacter baumannii.

- Anucha Apisarnthanarak (Thammasat University Hospital, Thailand)

Symposium 2


13:00 - 14:30

S2-1. Inborn errors of cytosolic RNA sensors and severe COVID-19

- Helen Su (National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA)

S2-2. Vaccination in post-pandemic era and impact on long COVID

- David Lye (National Centre for Infectious Diseases, Singapore)

S2-3. Viral shedding kinetics in patients with SARS-CoV-2 infection

- Sung-Han Kim (Asan Medical Center, Korea)

Symposium 3

Antimicrobial stewardship

13:00 - 14:30

S3-1. The current situation of Antimicrobial Stewardship Program in Asia-Pacific countries

- Masayuki Maeda (Showa University, Japan)

S3-2. Cutting-Edge Antimicrobial Stewardship: Strategies for Optimizing Therapy and Curbing Resistance in the Modern Era

- Sara Cosgrove (Johns Hopkins University School of Medicine, USA)

S3-3. Integrating Emerging Technologies: Pioneering the Next Frontier in Antimicrobial Stewardship

- Se Yoon Park (Hanyang University Hospital, Korea)

Keynote Lecture

15:00 - 17:40

K-1. Is antibiotic resistance stoppable?

- David M. Livermore (University of East Anglia, UK)

K-2. The Modern World of Infectious Diseases: A Growing Challenge

- Michael T. Osterholm (University of Minnesota, USA)

K-3. Vaccines for AMR: an Overview

- Jerome H. Kim (International Vaccine Institute)

K-4. Update on Actions and Opportunities on Antimicrobial Resistance at NIH/NIAID

- Dennis M. Dixon (National Institute of Allergy and Infectious Diseases, USA)
April 9 (Tue)
07:30 - 08:50 KSAT Workshop 3
Chair: TBD

Plenary Lecture 1

08:50 - 09:30

P-1. Challenges in addressing the red plague of GNBs

- David Paterson (National University of Singapore, Singapore)

Plenary Lecture 2

09:30 - 10:10

P-2. Shaping Tomorrow's Antimicrobial Stewardship: The Crucial Contribution of Academic Institution

- Sara Cosgrove (Johns Hopkins University School of Medicine, USA)

Symposium 4

Strategies and Breakthroughs in the Battle Against Gram-Positive Bacterial Infections

10:30 - 12:30

S4-1. Breaking New Ground in S. aureus Bacteremia: An Introduction to the SNAP Trial and Its Progress Thus Far

- Josh Davis (University of Newcastle, Australia)

S4-2. Update in Staphylococcus aureus Bacteremia

- Vance G. Fowler (Duke University Medical Center, USA)

S4-3. Periprosthetic Joint Infections caused by Staphylococcus aureus: current management approaches and antimicrobial strategies

- Jaime Lora-Tamayo (Hospital Univ. 12 de Octubre, Madrid, Spain)

S4-4. From Bedside to Bench and Back Again for MRSA Therapeutics

- Anton Y. Peleg (Alfred Hospital and Monash University, Australia)

Symposium 5

Diagnostics 1

10:30 - 12:30

S5-1. Overview of Syndromic Testing: Rapid Multiplex PCR-guided Antimicrobial Stewardship and Clinical Benefits in Severe Infections

- Arthur C. Jeng (David Geffen School of Medicine, USA)

S5-2. Syndromic testing of respiratory infections

- Tae Yeul Kim (Samsung Medical Center, Korea)

S5-3. Syndromic testing of gastrointestinal infections

- Sung Jin Jo (Eunpyeong St. Mary's Hospital, Korea)

S5-4. Syndromic testing of bone and joint infection

- Robin Patel (Mayo Clinic, USA)

Symposium 6


10:30 - 12:30

S6-1. Antibiotic Therapy for Special Populations

- Eun Kyoung Chung (Kyung Hee University College of Pharmacy, Korea)

S6-2. Caution!: interpretation of plasma protein binding in PK/PD

- Dong-Seok Yim (College of Medicine, The Catholic Univ of Korea, Korea)

S6-3. In vitro assessment of antimicrobial drug effect to guide personalized combination therapy.

- Vincent H. Tam (University of Houston, USA)

S6-4. Microdialysis for measurement of tissue antibiotic concentration

- Andrea René Jørgensen (Aarhus University Hospital, Denmark)

Plenary Lecture 3

15:00 - 15:40

P-3. Artificial intelligence: A new weapon to fight infectious diseases

- Jae-Hoon Song (Asia Pacific Foundation for Infectious Diseases, Korea)

Plenary Lecture 4

15:40 - 16:20

P-4. Research Progress on Persistent MRSA Infection

- Vance G. Fowler (Duke University Medical Center, USA)

Symposium 7

Symposia: One health and antimicrobial resistance

16:40 - 18:10

S7-1. One Health Antibiotic Stewardship Collaborative

- Amanda Beaudoin (University of Minnesota, USA)

S7-2. The transmission of antimicrobial resistance at the human-animal-environment interface with genomics

- Mashkoor Mohsin (University of Agriculture, Faisalabad, Pakistan)

S7-3. International trends in research on antibiotic resistance from the perspective of One Health

- Gyu-Sung Cho (Max Rubner-Institut Federal Research Institute of Nutrition and Food, Germany)

S7-4. Phylogenomic Analysis of Carbapenem-resistant Enterobacterales in a Veterinary Hospital

- Keun Seok Seo (Mississippi State University College of Veterinary Medicine, USA)

Symposium 8

Infection prevention and control 1: Updates in infection prevention practices & research

16:40 - 18:10

S8-1. Back to the basics: hand hygiene update

- Stephan Harbarth (Geneva University Hospitals, Switzerland)

S8-2. Prevention of Non-Ventilator Hospital Acquired Pneumonia

- Michael Klompas (Harvard Medical School, USA)

S8-3. Automation in the practice of infection prevention and control

- Sun Young Cho (Samsung Medical Center, Korea)

Symposium 9

Latest advances of microbiome research on infectious diseases

16:40 - 18:10

S9-1. Understanding of human microbiome from an ecological perspective

- Bong-Soo Kim (Hallym University, Korea)

S9-2. Key determinants of success in fecal microbiota transplantation: from microbiome to clinic

- Serena Porcari (IRCCS Fondazione Policlinico Universitario ‘Agostino Gemelli’, Italy)

S9-3. Strategies to Restore Colonization Resistance with Microbiome-based Therapeutics

- Matthew Sorbara (University of Guelph, Canada)
April 10 (Wed)
07:30 - 08:50 KSAT Workshop 4
Big Data
Chair: Jang Wook Sohn (Korea University College of Medicine, Korea)

Plenary Lecture 5

08:50 - 09:30

P-5. Current Status of Shorter Tuberculosis Treatment

- Jae-Joon Yim (Seoul National University College of Medicine, Korea)

Plenary Lecture 6

09:30 - 10:10

P-6. Diagnostic Stewardship

- Robin Patel (Mayo Clinic, USA)

Symposium 10


10:30 - 12:30

S10-1. respiratory virus, RSV etc, maternal immunization

- Helen Y. Chu (University of Washington, USA)

S10-2. Bacterial-Viral Co-infection

- Cheng-Hsun Chiu (Chang Gung Memorial Hospital, Taiwan)

S10-3. Cytomegalovirus infection and drug resistance

- Yae-Jean Kim (Samsung Medical Center, Korea)

S10-4. Unveiling the hidden burden of respiratory virus infections in adult

- Ji Yun Noh (Korea University College of Medicine, Korea)

Symposium 11

Infection prevention and control 2: How to mitigate the risk using the environmental management

10:30 - 12:30

S11-1. How to mitigate multidrug resistant GNB spread through water control in healthcare settings

- Jiwon Jung (Asan Medical Center, Korea)

S11-2. Control Clostridioides difficile in healthcare: what to consider?

- Anucha Apisarnthanarak (Thammasat University Hospital, Thailand)

S11-3. How to reduce the risk of MDR pathogens in ICUs using environmental design: single rooms are better?

- Pyeong Gyun Choe (Seoul National University, Korea)

Symposium 12

Diagnostics 2

10:30 - 12:30

S12-1. Clinical utility of biomarkers in infectious diseases

- Ki Ho Hong (Yonsei University College of Medicine, Korea)

S12-2. Application of NGS in clinical microbiology and infection control

- Dokyun Kim (Yonsei University College of Medicine, Korea)

S12-3. Enhancing clinical impact of new parasitic disease detection technologies

- Po-Ren Hsueh (China Medical University, China Medical University Hospital, Taiwan)

S12-4. Rapid detection of CPE: Enhancing patient treatment and infection control

- Namhee Kim (SMG-SNU Boramae Medical Center, Korea)

Symposium 13

Fungus: Antifungal Resistance; current trends and strategies to overcome

15:00 - 16:30

S13-1. Candida auris: epidemiology and antifungal resistance

- Jong Hee Shin (Chonnam National University Medical School, Korea)

S13-2. Antifungal stewardship in critically ill patients

- Melissa Johnson (Duke University School of Medicine, USA)

S13-3. The antifungal pipeline: advances in the treatment of invasive mycoses

- Ilan Schwartz (Duke University School of Medicine, USA)

Symposium 14

The path that ends the era of HIV

15:00 - 16:30

S14-1. Rapid ART initiation: why, how, and what to start

- Chien-Ching Hung (National Taiwan University Hospital Yunlin Branch, Taiwan)

S14-2. Moving the needle: The role and impact of HIV self-testing on early diagnosis of HIV in Asia-Pacific

- Chen Seong Wong (National Centre for Infectious Diseases, Singapore)

S14-3. Pre-exposure prophylaxis: A pillar for ending the HIV epidemic

- Jun Yong Choi (Yonsei University College of Medicine, Korea)

Symposium 15


15:00 - 16:30

S15-1. Influenza vaccination strategies in older adults

- Benjamin Cowling (The University of Hong Kong, Hong Kong)

S15-2. Understanding vaccine effectiveness in terms of T cell immunity

- Eui-Cheol Shin (KAIST Graduate School of Medical Science, Korea)

S15-3. Pneumococcal vaccination strategies in adult population

- Ki Tae Kwon (Kyungpook National University School of Medicine, Korea)